AURA Stock Price
Aura Biosciences, Inc.
AURA stock price is $6.10 (-3.79% on the day), giving Aura Biosciences, Inc. a market cap of $632.60M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
AURA Stock Overview
- Price
- $6.10
- Previous close
- $6.34
- Open
- $6.31
- Market cap
- $632.60M
- P/E ratio
- -6.0
- 52-week range
- $4.73 - $9.54
- 1-year price target
- $16.80
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSD
- MarketXLS Rank
- 31
About Aura Biosciences, Inc.
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is based in Boston, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AURA | $6.10 | -3.8% | 762.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |